• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国-奥地利关于妊娠和 HIV1 暴露新生儿的 HIV1 治疗建议,2008 年更新。

German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.

机构信息

University Medical Centre Mannheim, Pediatric Clinic, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.

出版信息

Eur J Med Res. 2009 Nov 3;14(11):461-79. doi: 10.1186/2047-783x-14-11-461.

DOI:10.1186/2047-783x-14-11-461
PMID:19948442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3352287/
Abstract

In Germany during the last years about 200-250 HIV1-infected pregnant women delivered a baby each year, a number that is currently increasing. To determine the HIV-status early in pregnancy voluntary HIV-testing of all pregnant women is recommended in Germany and Austria as part of prenatal care. In those cases, where HIV1-infection was known during pregnancy, since 1995 the rate of vertical transmission of HIV1 was reduced to 1-2%. - This low transmission rate has been achieved by the combination of anti-retroviral therapy of pregnant women, caesarean section scheduled before onset of labour, anti-retroviral post exposition prophylaxis in the newborn and refraining from breast-feeding by the HIV1-infected mother. To keep pace with new results in research, approval of new anti-retroviral drugs and changes in the general treatment recommendations for HIV1-infected adults, in 1998, 2001, 2003 and 2005 an interdisciplinary consensus meeting was held. Gynaecologists, infectious disease specialists, paediatricians, pharmacologists, virologists and members of the German AIDS Hilfe (NGO) were participating in this conference to update the prevention strategies. A fifth update became necessary in 2008. The updating process was started in January 2008 and was terminated in September 2008. The guidelines provide new recommendations on the indication and the starting point for HIV-therapy in pregnancies without complications, drugs and drug combinations to be used preferably in these pregnancies and updated information on adverse effects of anti-retroviral drugs. Also the procedures for different scenarios and risk constellations in pregnancy have been specified again. - With these current guidelines in Germany and Austria the low rate of vertical HIV1-transmission should be further maintained.

摘要

在过去的几年中,德国每年约有 200-250 名 HIV1 感染的孕妇分娩,这个数字目前正在增加。为了在孕期尽早确定 HIV 状态,德国和奥地利建议所有孕妇自愿进行 HIV 检测,这是产前护理的一部分。在那些已知孕妇感染 HIV1 的情况下,自 1995 年以来,HIV1 的垂直传播率已降低至 1-2%。- 这种低传播率是通过对孕妇进行抗逆转录病毒治疗、在分娩前计划剖腹产、对新生儿进行抗逆转录病毒暴露后预防以及感染 HIV1 的母亲避免母乳喂养来实现的。为了跟上研究的新成果,批准新的抗逆转录病毒药物并改变针对 HIV1 感染成人的一般治疗建议,1998 年、2001 年、2003 年和 2005 年举行了一次跨学科共识会议。妇科医生、传染病专家、儿科医生、药理学家、病毒学家和德国艾滋病援助组织(非政府组织)的成员参加了这次会议,以更新预防策略。2008 年又进行了第五次更新。更新过程于 2008 年 1 月开始,并于 2008 年 9 月结束。这些指南提供了关于无并发症妊娠中 HIV 治疗的适应证和起始点的新建议、这些妊娠中首选的药物和药物组合以及抗逆转录病毒药物不良反应的最新信息。还再次规定了不同情况下和不同风险组合的程序。- 通过德国和奥地利目前的这些指南,应进一步维持 HIV1 垂直传播的低率。

相似文献

1
German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.德国-奥地利关于妊娠和 HIV1 暴露新生儿的 HIV1 治疗建议,2008 年更新。
Eur J Med Res. 2009 Nov 3;14(11):461-79. doi: 10.1186/2047-783x-14-11-461.
2
German-Austrian recommendations for HIV-therapy in pregnancy and in HIV-exposed newborn - update 2005.德国-奥地利关于孕期及暴露于HIV的新生儿的HIV治疗建议——2005年更新版
Eur J Med Res. 2006 Sep 29;11(9):359-76.
3
German-Austrian recommendations for HIV-therapy in pregnancy--common declaration of The German AIDS-society (DAIG), The Austrian AIDS-society (OEAG) as well as The Robert-Koch Institute Berlin (RKI), The German Association of Physicians specialized in HIV Care (DAGNAE), The German Society of Pediatric and Youth Medicine (DGKJ), The German AIDS Pediatric Association (PAAD), The German Society of Obstetrics and Gynecology (DGGG), The National Reference Center for Retroviruses (NRZ), German AIDS Assistance (DAH).德国-奥地利孕期艾滋病治疗建议——德国艾滋病协会(DAIG)、奥地利艾滋病协会(OEAG)、柏林罗伯特·科赫研究所(RKI)、德国艾滋病护理专家医师协会(DAGNAE)、德国儿科学与青少年医学学会(DGKJ)、德国艾滋病儿科学会(PAAD)、德国妇产科学会(DGGG)、国家逆转录病毒参考中心(NRZ)、德国艾滋病援助组织(DAH)的共同声明
Eur J Med Res. 2002 Oct 29;7(10):417-33.
4
German-Austrian recommendations for HIV-therapy in pregnancy: update May 2003.德国-奥地利孕期艾滋病治疗建议:2003年5月更新
Eur J Med Res. 2004 Jun 30;9(6):287-303.
5
Pediatric aspects of HIV1-infection--an overview.人类免疫缺陷病毒1型感染的儿科问题——概述
Minerva Pediatr. 2010 Aug;62(4):371-87.
6
[German-Austrian recommendations for HIV treatment during pregnancy and for newborns exposed to HIV--Update 2008].[德国-奥地利关于孕期艾滋病治疗及艾滋病暴露新生儿的建议——2008年更新版]
Dtsch Med Wochenschr. 2009 Jan;134 Suppl 1:S40-54. doi: 10.1055/s-0028-1123974. Epub 2009 Jan 26.
7
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.孕妇HIV感染管理及预防HIV母婴传播指南。
HIV Med. 2005 Jul;6 Suppl 2:107-48. doi: 10.1111/j.1468-1293.2005.00302.x.
8
Antiretroviral use during pregnancy for treatment or prophylaxis.妊娠期抗逆转录病毒治疗或预防应用。
Expert Opin Pharmacother. 2011 Aug;12(12):1875-85. doi: 10.1517/14656566.2011.584062. Epub 2011 May 3.
9
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.美国公共卫生服务部特别工作组关于在感染HIV-1的孕妇中使用抗逆转录病毒药物以促进孕产妇健康及采取干预措施减少美国围产期HIV-1传播的建议。
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.
10
Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.尼日利亚大学教学医院的自愿咨询与检测服务接受情况、奈韦拉平使用情况及婴儿喂养方式
J Obstet Gynaecol. 2008 Apr;28(3):276-9. doi: 10.1080/01443610802042639.

引用本文的文献

1
HIV Prophylaxis in High Risk Newborns: An Examination of Sociodemographic Factors in an Inner City Context.高危新生儿的艾滋病病毒预防:对市中心环境下社会人口学因素的考察
Can J Infect Dis Med Microbiol. 2016;2016:2782786. doi: 10.1155/2016/2782786. Epub 2016 Apr 3.
2
Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study.三级转诊中心HIV阳性女性及其新生儿中巨细胞病毒合并感染的发生率:一项队列研究。
Med Microbiol Immunol. 2016 Feb;205(1):63-71. doi: 10.1007/s00430-015-0427-9. Epub 2015 Jul 9.

本文引用的文献

1
[Not Available].[无可用内容]。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 1999 Jul;42(7):553-557. doi: 10.1007/s001030050154.
2
Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.在法国国家艾滋病研究机构(ANRS)围产期队列中,尽管进行了抗逆转录病毒治疗,但仍存在母婴HIV传播情况。
AIDS. 2008 Jan 11;22(2):289-99. doi: 10.1097/QAD.0b013e3282f3d63c.
3
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases.孕期接受含替诺福韦治疗的母亲所生儿童的先天性肾盂扩张:两例报告。
Infection. 2007 Dec;35(6):474-6. doi: 10.1007/s15010-007-6358-7. Epub 2007 Nov 22.
4
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.孕期使用阿扎那韦联合低剂量利托那韦:药代动力学与胎盘转运
AIDS. 2007 Nov 30;21(18):2409-15. doi: 10.1097/QAD.0b013e32825a69d1.
5
PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events.PREDICT-1(CNA106030):第一项旨在减少药物不良事件的药物遗传学筛查的有动力、前瞻性试验。
Pharm Stat. 2008 Apr-Jun;7(2):121-9. doi: 10.1002/pst.286.
6
CD4+ count-guided interruption of antiretroviral treatment.基于CD4细胞计数指导的抗逆转录病毒治疗中断
N Engl J Med. 2006 Nov 30;355(22):2283-96. doi: 10.1056/NEJMoa062360.
7
Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir.使用恩夫韦肽和替拉那韦联合进行孕产妇治疗预防多药耐药HIV-1的母婴传播
AIDS. 2006 Jun 26;20(10):1465-7. doi: 10.1097/01.aids.0000233587.94961.4f.
8
Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta.恩夫韦肽可预防孕期多药耐药HIV-1的垂直传播,但不能穿过胎盘。
AIDS. 2006 Jan 9;20(2):297-9. doi: 10.1097/01.aids.0000200535.02232.1b.
9
Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance.停止治疗8周后血浆中可检测到依非韦伦,随后出现非核苷类逆转录酶抑制剂相关耐药。
AIDS. 2005 Oct 14;19(15):1716-7. doi: 10.1097/01.aids.0000186828.99032.60.
10
Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.对于HIV RNA持续处于中等水平且CD4+细胞计数>400个/微升的患者,高效抗逆转录病毒治疗能否中断?对免疫病毒学参数的影响。
J Med Virol. 2005 Oct;77(2):164-72. doi: 10.1002/jmv.20452.